Yayın:
Design, Synthesis, and Anticancer Evaluation of New Small-Molecule EGFR Inhibitors Targeting NSCLC and Breast Cancer

dc.contributor.authorSEVER, BELGİN
dc.contributor.authorMasami Otsuka
dc.contributor.authorMikako Fujita
dc.contributor.authorHalil I. Ciftci
dc.contributor.orcid0000-0003-4847-9711
dc.contributor.orcid0000-0002-2968-3939
dc.contributor.orcid0000-0001-6705-4052
dc.contributor.orcid0000-0002-9796-7669
dc.date.accessioned2025-11-13T16:39:06Z
dc.date.issued2025-07-22
dc.identifier.doihttps://doi.org/10.3390/ijms26157065
dc.identifier.endpage7065
dc.identifier.issn1422-0067
dc.identifier.issue15
dc.identifier.openalexW4412570316
dc.identifier.startpage7065
dc.identifier.urihttps://hdl.handle.net/11421/10322
dc.identifier.urihttps://doi.org/10.3390/ijms26157065
dc.identifier.volume26
dc.language.isoen
dc.relation.ispartofInternational Journal of Molecular Sciences
dc.rightsopenAccess
dc.subjectCytotoxicity
dc.subjectJurkat cells
dc.subjectA549 cell
dc.subjectApoptosis
dc.subjectCancer research
dc.subjectChemistry
dc.subjectLung cancer
dc.subjectCancer cell
dc.subjectPharmacology
dc.subjectBreast cancer
dc.subjectIn silico
dc.subjectEGFR inhibitors
dc.subjectMCF-7
dc.subjectCancer
dc.subjectEpidermal growth factor receptor
dc.subjectIn vitro
dc.subjectBiology
dc.subjectBiochemistry
dc.subjectMedicine
dc.subjectImmunology
dc.subjectReceptor
dc.subjectOncology
dc.subjectT cell
dc.subjectInternal medicine
dc.subjectGene
dc.subject.sdg3
dc.titleDesign, Synthesis, and Anticancer Evaluation of New Small-Molecule EGFR Inhibitors Targeting NSCLC and Breast Cancer
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5040352588

Dosyalar

Koleksiyonlar